Latest benign tumor Stories
LYNBROOK, N.Y., Oct. 16, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
Software that can recognize patterns in data is commonly used by scientists and economics.
Rhode Island Hospital researchers have found that the absence of the Shp-2 enzyme near specialized cartilage cells can lead to the development of multiple benign cartilage tumors in mice, a model that recapitulates the rare human tumor syndrome metachondromatosis.
Uterine leiomyomata, or fibroids, are benign tumors that nevertheless affect the health of millions of women.
Modern day exposure to pollution, toxins, radiation, and even unhealthy foods are considerable factors in the risk of future cancer. And because these factors are associated with modern society, it is especially rare to find cancers in older civilizations.
A group of scientists led by UT Southwestern Medical Center has reported the first successful blocking of tumor development in a genetic mouse model of an incurable human cancer.
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Patients with chronic constipation may be at increased risk of developing colorectal cancer and benign neoplasms.
- The act of sweetening by admixture of some saccharine substance.